Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-21-038459

Options or other derivatives

  • Director acquired 15,606 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
SCHIFF ANDREW N Director 2021-06-03 Grant or award · Stock Option (Right to Buy) +12,250 12,250 D: show line 1 in the form
SCHIFF ANDREW N Director 2021-06-03 Grant or award · Restricted Stock Units +3,356 3,356 D: show line 2 in the form
Loading xslF345X03/doc4.xml…